Objective To study the effect of calcium ion concentration in peritoneal dialysate on peritoneal fibrosis, epithelial mesenchymal transition (EMT) and endoplasmic reticulum stress (ERS) of peritoneal dialysis patients. Method A randomized controlled study was conducted on patients who underwent continuous non-bedridden peritoneal dialysis using standard calcium peritoneal dialysate. They were divided into low calcium group and control group. Patients in low calcium group switched to low calcium peritoneal dialysate while those in the control group continued to use the peritoneal dialysate with standard calcium concentration. The enrollment time point was set at 0 month and the end of the experiment was set after 6 months. Their clinical data at the time of enrollment were recorded. The outflow dialysates at 0 and 6 months were collected to measure the contents of transforming growth factors-β1 (TGF-β1), fibronectin (FN) and collagen-I (Col-I), and the expression levels of E-cadherin, N-cadherin, ZO-1, α-smooth muscle actin (α-SMA), CCAAT enhancer binding protein homologous protein (CHOP), phosphorylated protein kinase R-like endoplasmic reticulum kinase (p-PERK), phosphorylated eukaryotic translation initiation factor 2 α (p-eIF2α) and transcription activating factor 4 (ATF4). Results A total of 49 patients were enrolled, including 24 in low calcium group and 25 in control group. After 6 months of treatment, the contents of TGF-β1, FN, Col-I and the expression levels of α-SMA, N-cadherin, p-PERK, p-eIF2α, ATF4 and CHOP were lower in low calcium group than in control group (t=4.599, 2.161, 6.557, 9.357, 8.565, 8.634, 7.518, 8.842 and 10.989 respectively; P＜0.001, =0.036, ＜0.001, ＜0.001, ＜0.001, ＜0.001, ＜0.001, ＜0.001 and ＜0.001 respectively), while the expression levels of E-cadherin and ZO-1were higher in low calcium group than in control group (t=16.684 and 22.273; P＜0.001 and＜0.001). Conclusion Low calcium dialysate can alleviate peritoneal fibrosis, of which the molecular mechanism may relate to the inhibition of EMT and ERS by low calcium dialysate.
GUO Bao-Zhu
,
CHENG Jin-Xiu
,
JIN Xin
,
HE Yu-Tao
,
SUN Xian-Min
. Effect of calcium ion concentration in peritoneal dialysate on peritoneal fibrosis and endoplasmic reticulum stress of peritoneal dialysis patients[J]. Chinese Journal of Blood Purification, 2023
, 22(11)
: 805
-809
.
DOI: 10.3969/j.issn.1671-4091.2023.11.002
[1]Masola V, Bonomini M, Borrelli S, et al. Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis[J]. International Journal of Molecular Sciences, 2022, 23(9): 4831.
[2]Yi W, Shi Y, Tao M, et al. Peritoneal fibrosis and epigenetic modulation[J]. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2021, 41(2): 168-178.
[3]张红娟,赵素芳. 低钙腹膜透析液对慢性肾衰竭患者血清钙磷代谢、血红蛋白及残余肾功能的影响[J]. 临床研究, 2022, 30(8): 70-73.
[4]李涛,刘一卓,冯爱桥. 标准钙及低钙腹膜透析液对非卧床持续性腹膜透析患者预后的影响对比[J]. 中国医刊, 2015, 50(12):64-67.
[5]Xia Y, Wan C, Zhang Q, et al. Role of IGF-1R in epithelial-mesenchymal transdifferentiation of human peritoneal mesothelial cells[J]. Clinical and experimental nephrology, 2022, 26(7): 630-639.
[6]Shin H, Ryu E, Oh E, et al. Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells[J]. Laboratory investigation; a journal of technical methods and pathology, 2015, 95(10 ): 1157-1173.
[7]曾珏, 薛增奇, 赵章健, 等. 不同钙离子浓度腹膜透析液对腹膜透析患者腹膜间皮细胞的影响[J]. 现代实用医学, 2020, 32(12): 1460-1461.
[8]彭翔, 刘伏友, 孙林, 等. 不同浓度钙离子对人腹膜间皮细胞E-钙黏蛋白、成纤维细胞特异蛋白、波形蛋白表达的影响[J]. 肾脏病与透析肾移植杂志, 2011, 20(1): 29-33.
[9]Shi P, Zhan Z, Ye X, et al. The antioxidative effects of empagliflozin on high glucose?induced epithelial-mesenchymal transition in peritoneal mesothelial cells via the Nrf2/HO-1 signaling[J]. 2022, Renal failure, 44(1): 1528-1542.
[10]Felipe S, Felipe S, Pablo T, et al. Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca2+ and Na+ Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt Pathway[J]. Frontiers in Physiology, 2017, 8: 379.
[11]Miao C, Xue X, Dai L, et al. The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis[J]. Seminars in dialysis, 2020, 34(1): 51-56.
[12]Lho Y, Do J, Heo J, et al. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells[J]. International Journal of Molecular Sciences, 2021, 22(9): 4739.
[13]Xie S, Xu F, Lu Y, et al. Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis[J]. Frontiers in Pharmacology, 2022, 13: 890881.
[14]郑峰, 姜燕, 臧秀娟, 等. 老年腹膜透析患者腹膜纤维化与腹膜透析液中糖原合酶激酶-3β、β连环蛋白水平的相关性研究[J]. 老年医学与保健, 2022, 28(3): 612-615.
[15]Sun Z, Ning Q, Li H, et al. Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway[J]. Journal of receptor and signal transduction research, 2020, 42(1): 1-7.
[16]童孟立. 腹膜透析患者腹膜纤维化发生机制及防治的研究进展[J]. 浙江医学, 2020, 42(6): 529-532.
[17]Huang CY, Deng JS, Huang WC, et al. Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Hispolon in Mice, Through Regulating the TLR4/PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 Pathways, and Suppressing Oxidative Stress-Mediated ER Stress-Induced Apoptosis and Autophagy[J]. Nutrients, 2020, 12(6):1742.
[18]Hou X, Li L, Chen S, et al. MKP-1 Overexpression Reduces Postischemic Myocardial Damage through Attenuation of ER Stress and Mitochondrial Damage[J]. Oxid Med Cell Longev, 2021, 2(2021): 8905578.
